Disease Landscape and Forecast Insights
Comprehensive market intelligence and actionable insights help you optimize your long-term disease strategy
SPECIAL REPORT: The Launches of Opsumit, Adempas, and Orenitram into the Pulmonary Arterial Hypertension Market
Pulmonary arterial hypertension (PAH) is a severe and debilitating disease, with rapid disease progression and high rates of mortality. As a consequence, the necessity for effective treatments are…